title: [Are the most recent basal insulins really the most innovative?].
authors.affiliation: Área de Farmacología, Facultad de Fisioterapia de Soria, Universidad de Valladolid, Soria, España. Electronic address: claudo@biocel.uva.es.
authors.forename: Consuelo
authors.initials: C
authors.lastname: Laudo Pardos
authors.affiliation: Unidad de Endocrinología, Servicio de Medicina Interna, Complejo Hospitalario de Soria, Soria, España.
authors.forename: Víctor
authors.initials: V
authors.lastname: Puigdevall Gallego
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D055808:Drug Discovery; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D049528:Insulin, Long-Acting / Q000627:therapeutic use*; D035703:Therapies, Investigational; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting